Switch theme
Sign up to access all valuation multiples
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
2016
50
Last FY Revenue n/a
LTM EBITDA -$92.6M
$56.4M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cybin has a last 12-month revenue (LTM) of n/a and a last 12-month EBITDA of -$92.6M.
In the most recent fiscal year, Cybin achieved revenue of n/a and an EBITDA of -$56.6M.
Cybin expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cybin valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | n/a | XXX | n/a | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA | -$92.6M | XXX | -$56.6M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBIT | -$95.7M | XXX | -$56.9M | XXX | XXX | XXX |
| EBIT Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| Net Profit | -$80.0M | XXX | -$56.4M | XXX | XXX | XXX |
| Net Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cybin's stock price is CAD 11 (or $8).
Cybin has current market cap of CAD 232M (or $168M), and EV of CAD 78.2M (or $56.4M).
See Cybin trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $56.4M | $168M | XXX | XXX | XXX | XXX | $-3.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cybin has market cap of $168M and EV of $56.4M.
Cybin's trades at n/a EV/Revenue multiple, and -0.7x EV/EBITDA.
Equity research analysts estimate Cybin's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cybin has a P/E ratio of -2.1x.
See valuation multiples for Cybin and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $168M | XXX | $168M | XXX | XXX | XXX |
| EV (current) | $56.4M | XXX | $56.4M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | n/a | XXX | XXX | XXX |
| EV/EBITDA | -0.6x | XXX | -0.7x | XXX | XXX | XXX |
| EV/EBIT | -0.6x | XXX | -0.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | -2.1x | XXX | -2.3x | XXX | XXX | XXX |
| EV/FCF | -0.8x | XXX | -0.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCybin's revenue per employee in the last FY averaged n/a, while opex per employee averaged $1.1M for the same period.
Cybin's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cybin's rule of X is n/a (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cybin and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | -19% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $1.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cybin acquired XXX companies to date.
Last acquisition by Cybin was XXXXXXXX, XXXXX XXXXX XXXXXX . Cybin acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cybin founded? | Cybin was founded in 2016. |
| Where is Cybin headquartered? | Cybin is headquartered in Canada. |
| How many employees does Cybin have? | As of today, Cybin has 50 employees. |
| Who is the CEO of Cybin? | Cybin's CEO is Mr. Douglas Drysdale. |
| Is Cybin publicy listed? | Yes, Cybin is a public company listed on NEOE. |
| What is the stock symbol of Cybin? | Cybin trades under CYBN ticker. |
| When did Cybin go public? | Cybin went public in 2020. |
| Who are competitors of Cybin? | Similar companies to Cybin include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Cybin? | Cybin's current market cap is $168M |
| Is Cybin profitable? | Yes, Cybin is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cybin? | Cybin's last 12 months EBITDA is -$92.6M. |
| What is the current EV/EBITDA multiple of Cybin? | Current EBITDA multiple of Cybin is -0.6x. |
| What is the current FCF of Cybin? | Cybin's last 12 months FCF is -$72.7M. |
| What is the current EV/FCF multiple of Cybin? | Current FCF multiple of Cybin is -0.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
